drugset / Trial / NCT03853694
Efficacy and Safety of EXPAREL Versus Standard of Care (SoC) in Subjects Undergoing Elective Cesarean Section
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare total opioid consumption by subjects in different treatment groups. Another purpose of this study is to assess how well EXPAREL works, collect any safety data and assess your satisfaction using EXPAREL.
Timeline
- Start
- 2019-03-04
- Primary completion
- 2020-01-09
- Completion
- 2020-01-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bupivacaine | Other / unclassified | 266 mg | Other |
| Subject | Morphine | Other / unclassified | 50 ug | Intrathecal |
| Subject | Morphine | Other / unclassified | 150 ug | Intrathecal |
Indications
No indication recorded.